Logo

Strides Pharma Science Share Price

NSE: STAR
|
Pharmaceuticals
₹ 1,126.80
+₹0.40 (0.04%)
1D
Last updated 03 Jul, 2026, 15:58 IST

Strides Pharma Science Share Price Today

As of 5 Jul 2026, Strides Pharma Science share price is ₹1,126.80. The stock opened at ₹1,134.90, compared to its previous close of ₹1,126.40. During today's trading session, Strides Pharma Science share price moved in the range of ₹1,113.20 to ₹1,138.00, with an average price of ₹1,125.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹768.65 and a high of ₹1,231.00. On the performance front, Strides Pharma Science share price has increased by 25.10% over the last six months and is up 27.50% on a year-on-year basis.

₹1,113.20
0.04% up today
₹1,138.00
1D LOW
1D HIGH

Strides Pharma Science Returns Calculator

Open
₹1,134.90
High
₹1,138.00
Low
₹1,113.20
Prev. close
₹1,126.40
Circuit
L
H
₹901.50
₹1,352.10
52-week
L
H
₹768.65
₹1,231.00

Strides Pharma Science Shareholder Returns

Strides Pharma Science Share Price History

Mkt Cap Cr
10,379.60
P/E
18.07
P/B
3.34
ROE
17.90%
D/E
0.36
ROCE
17.30%
Div. Yield
0.44%
EPS(TTM)
19.92
Turnover
0.61
EV/EBITDA
11.08
Net Margin
0.00%
Op. Margin
0.00%
ROA
8.29%
Quick Ratio
0.00
Curr. Ratio
2.80
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Strides Pharma outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Strides Pharma appears to be fairly valued compared to its peers
Step 3 of 5
Earnings
Neutral
Strides Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Strides Pharma Science Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹4,565.34₹3,890.13₹3,688.39₹3,070.25
Other Income₹58.72₹39.70₹90.33₹131.99
Total Revenue₹4,624.06₹3,929.83₹3,778.72₹3,202.24
Total Expenses₹4,203.63₹3,801.61₹3,762.60₹3,500.11
Profit Before Tax₹486.92-₹114.79-₹286.20-₹652.51
Tax₹77.52₹29.11-₹55.30-₹178.26
Profit After Tax₹409.41-₹143.90-₹230.90-₹474.25
EPS - Basic₹390.55-₹7.76-₹22.49-₹51.28
EPS - Diluted₹390.50-₹7.76-₹22.49-₹51.28

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹3,675.03-₹62.72-₹267.63-₹652.51
Income before WC changes₹781.06₹755.55₹414.56-₹70.24
Change in Assets-₹268.65₹69.79-₹355.52-₹30.61
Change in Liabilities₹104.93-₹148.53-₹102.28-₹159.30
Change in WC-₹163.73-₹78.73-₹457.80-₹189.90
Cash flow from Operations₹684.37₹701.07₹44.41-₹257.82
Cash flow from Investing-₹89.69-₹150.25₹302.47-₹118.73
Cash flow from Financing-₹642.58-₹693.32-₹213.92₹421.32
Total Cash Flow-₹47.90-₹142.51₹132.96₹44.77
Cash (Start of the year)₹161.02₹303.50₹170.73₹125.83
Cash (End of the year)₹112.56₹161.02₹303.50₹170.73

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2,949.81₹2,870.76₹3,395.06₹3,614.03
Current Assets₹3,098.91₹2,969.00₹3,243.36₹3,361.83
Total Assets₹6,048.73₹5,839.76₹6,638.42₹6,975.86
Current Liabilities₹2,591.52₹2,879.26₹2,990.20₹3,411.68
Net Current Asset₹507.39₹89.74₹253.16-₹49.84
Non-Current Liabilities₹870.74₹888.79₹1,475.34₹1,180.87
Equity Capital₹2,586.46₹2,071.71₹2,172.88₹2,383.32
Total Equity & Liabilities₹6,048.73₹5,839.76₹6,638.42₹6,975.86

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹2,139.42₹1,866.12₹1,854.50₹1,979.00
Other Income₹46.19₹58.71₹84.07₹123.49
Total Revenue₹2,185.61₹1,924.83₹1,938.56₹2,102.49
Total Expenses₹2,107.50₹1,942.40₹1,988.32₹2,080.98
Profit Before Tax₹78.08-₹22.93-₹64.76₹21.51
Tax₹18.93₹1.34-₹69.44-₹158.68
Profit After Tax₹59.16-₹24.28₹4.68₹180.19
EPS - Basic₹313.68₹4.90₹0.52₹20.08
EPS - Diluted₹313.68₹4.89₹0.52₹20.08

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹2,905.14₹40.99-₹64.76₹21.51
Income before WC changes₹282.39₹291.89₹108.11₹96.68
Change in Assets₹39.19-₹244.22₹20.63-₹289.10
Change in Liabilities-₹22.61-₹115.39₹13.18-₹111.66
Change in WC₹16.58-₹359.60₹33.81-₹400.77
Cash flow from Operations₹421.48-₹14.01₹241.74-₹282.69
Cash flow from Investing-₹137.59-₹69.57-₹182.58₹18.78
Cash flow from Financing-₹370.32₹93.34₹10.82₹250.73
Total Cash Flow-₹86.42₹9.77₹69.98-₹13.18
Cash (Start of the year)₹92.75₹82.11₹12.12₹25.30
Cash (End of the year)₹6.33₹92.75₹82.11₹12.12

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2,885.44₹3,490.70₹3,493.34₹3,458.61
Current Assets₹2,145.50₹2,411.18₹2,126.40₹1,975.25
Total Assets₹5,030.95₹5,901.87₹5,619.74₹5,433.86
Current Liabilities₹1,629.61₹2,085.14₹1,796.83₹1,841.32
Net Current Asset₹515.89₹326.04₹329.58₹133.92
Non-Current Liabilities₹208.60₹289.13₹367.86₹185.85
Equity Capital₹3,192.74₹3,527.60₹3,455.05₹3,406.68
Total Equity & Liabilities₹5,030.95₹5,901.87₹5,619.74₹5,433.86
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1126.8
115
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 115
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.22
Neutral
ATR (14)
34.16
Neutral
STOCH(9,6)
70.44
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
21.07
Bearish
UO(9)
46.74
Neutral
ROC(12)
2.19
Bullish
WillR(14)
-28.19
Neutral
Period
Simple value
Exponential vaue
5D
1108.72
1113.33
10D
1107.54
1105.21
20D
1078.57
1097.08
50D
1097.16
1073.92
100D
1003.08
1026.19

About Strides Pharma Science

Strides Pharma Science logo
ISIN
INE939A01011
Sector Market Cap
₹ 10,379.6 Cr

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Strides Pharma Science Financial Highlights

  • Revenue: Strides Pharma Science reported revenue of ₹5,009.39 crore in FY26 vs ₹4,624.06 crore in FY25. It showed an increase of 8.33% on a yearly basis.
  • Operating Profit: Strides Pharma Science reported an operating profit of ₹668.69 crore in FY26 vs ₹486.92 crore in FY25. It showed an increase of 37.33% on a year-on-year basis.
  • Net Profit: Strides Pharma Science reported a net profit of ₹574.52 crore in FY26 vs ₹3,597.51 crore in FY25. It showed a decrease of 84.03% on a yearly basis.

Strides Pharma Science Quarterly Result Highlights

  • Strides Pharma Science reported revenue of ₹1,331.60 crore in Mar 2026, compared with ₹1,301.51 crore in Dec 2025, representing an increase of 2.31% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported an operating profit of ₹148.05 crore in Mar 2026, compared with ₹245.48 crore in Dec 2025, representing a decrease of 39.69% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported a profit of ₹129.28 crore in Mar 2026, compared with ₹208.12 crore in Dec 2025, reflecting a decrease of 37.88% on a QoQ basis.
  • The earnings per share (EPS) of Strides Pharma Science stood at ₹390.55 during Mar 2026.
Know more
Promoters
27.91%
FII
28.68%
Other DII
5.88%
Retail and other
28.96%
Mutual funds
8.56%
Foreign institutions - FII
Compare against other stocks
Strides Pharma Science logo
Strides Pharma Science
Pharmaceuticals
Add Stock
Add Another

FAQs on Strides Pharma Science Share Price